Detailed Information on Publication Record
2023
ISG20L2: an RNA nuclease regulating T cell activation
RODRIGUEZ-GALAN, Ana, Sara G DOSIL, Anna VLČKOVÁ, Lola FERNANDEZ-MESSINA, Zuzana FEKETOVÁ et. al.Basic information
Original name
ISG20L2: an RNA nuclease regulating T cell activation
Authors
RODRIGUEZ-GALAN, Ana, Sara G DOSIL, Anna VLČKOVÁ (203 Czech Republic, belonging to the institution), Lola FERNANDEZ-MESSINA, Zuzana FEKETOVÁ (703 Slovakia, belonging to the institution), Julie POKORNÁ (203 Czech Republic, belonging to the institution), Irene FERNANDEZ-DELGADO, Emilio CAMAFEITA, Manuel Jose GOMEZ, Marta RAMIREZ-HUESCA, Cristina GUTIERREZ-VAZQUEZ, Fatima SANCHEZ-CABO, Jesus VAZQUEZ, Štěpánka VAŇÁČOVÁ (203 Czech Republic, belonging to the institution) and Francisco SANCHEZ-MADRID (guarantor)
Edition
Cellular and molecular life sciences, BASEL, BIRKHAUSER VERLAG AG, 2023, 1420-682X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 8.000 in 2022
RIV identification code
RIV/00216224:14740/23:00133564
Organization unit
Central European Institute of Technology
UT WoS
001058609400002
Keywords in English
Exonuclease; T cell; Immunoregulatory
Tags
International impact, Reviewed
Změněno: 1/8/2024 13:50, Mgr. Eva Dubská
Abstract
V originále
ISG20L2, a 3' to 5' exoribonuclease previously associated with ribosome biogenesis, is identified here in activated T cells as an enzyme with a preferential affinity for uridylated miRNA substrates. This enzyme is upregulated in T lymphocytes upon TCR and IFN type I stimulation and appears to be involved in regulating T cell function. ISG20L2 silencing leads to an increased basal expression of CD69 and induces greater IL2 secretion. However, ISG20L2 absence impairs CD25 upregula-tion, CD3 synaptic accumulation and MTOC translocation towards the antigen-presenting cell during immune synapsis. Remarkably, ISG20L2 controls the expression of immunoregulatory molecules, such as AHR, NKG2D, CTLA-4, CD137, TIM-3, PD-L1 or PD-1, which show increased levels in ISG20L2 knockout T cells. The dysregulation observed in these key molecules for T cell responses support a role for this exonuclease as a novel RNA-based regulator of T cell function.
Links
GA20-19617S, research and development project |
| ||
GA23-07372S, research and development project |
| ||
LQ1601, research and development project |
|